Nuvation Bio Inc. (NUVB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 60M 120M 180M Q4 '23: 0 Q1 '24: 0 Q2 '24: 1.4M Q3 '24: 2.2M Q4 '24: 7.9M Q1 '25: 11M Q2 '25: 14.4M Q3 '25: 26.7M Q4 '25: 62.9M Q1 '26: 143M Q2 '26: 169.9M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit TTM

-5M 0 5M 10M 15M Q4 '23: 0 Q1 '24: 0 Q2 '24: 88K Q3 '24: -700K Q4 '24: 795K Q1 '25: 1.8M Q2 '25: 4M Q3 '25: 14.5M Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Operating Income TTM

-750M -500M -250M 0 250M 500M 750M Q3 '21: -66M Q4 '21: -93.3M Q1 '22: -101M Q2 '22: -118.5M Q3 '22: -125M Q4 '22: -119.7M Q1 '23: -118.1M Q2 '23: -106.3M Q3 '23: -103.3M Q4 '23: -99.8M Q1 '24: -93.5M Q2 '24: -537.8M Q3 '24: -559.5M Q4 '24: -592.6M Q1 '25: -631.4M Q2 '25: -224.6M Q3 '25: -233M Q4 '25: -213.1M Q1 '26: -150.2M Q2 '26: -137.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-750M -500M -250M 0 250M 500M 750M Q3 '21: -79.2M Q4 '21: -86.8M Q1 '22: -87.7M Q2 '22: -103.3M Q3 '22: -108.5M Q4 '22: -104.2M Q1 '23: -104.6M Q2 '23: -90.4M Q3 '23: -82.9M Q4 '23: -75.8M Q1 '24: -68.9M Q2 '24: -510.7M Q3 '24: -532.3M Q4 '24: -567.9M Q1 '25: -606.4M Q2 '25: -202.9M Q3 '25: -217.5M Q4 '25: -204.6M Q1 '26: -146M Q2 '26: -149.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 3M 6M 9M Q4 '24: 7.1M Q1 '25: 7.1M Q2 '25: 5.9M Q3 '25: 7.7M Q4 '24 Q1 '25 Q2 '25 Q3 '25

Operating Cash Flow TTM

-210M -140M -70M 0 70M 140M 210M Q3 '21: -45.1M Q4 '21: -68.2M Q1 '22: -78.4M Q2 '22: -88.5M Q3 '22: -103.4M Q4 '22: -96.1M Q1 '23: -90.5M Q2 '23: -81.1M Q3 '23: -69.1M Q4 '23: -68M Q1 '24: -64.4M Q2 '24: -84.2M Q3 '24: -99.1M Q4 '24: -130.4M Q1 '25: -157.3M Q2 '25: -168.2M Q3 '25: -190M Q4 '25: -173.4M Q1 '26: -125.7M Q2 '26: -120.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 150K 300K 450K Q2 '21: 204K Q3 '21: 207.1K Q1 '22: 213.4K Q2 '22: 216.6K Q3 '22: 218.3K Q1 '23: 218.7K Q2 '23: 218.8K Q3 '23: 218.9K Q1 '24: 219K Q2 '24: 244.7K Q3 '24: 273.6K Q1 '25: 338.6K Q2 '25: 340.7K Q3 '25: 342.4K Q1 '26: 377.5K Q2 '26: 348.8K Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.60 -0.40 -0.20 0.00 0.20 0.40 0.60 Q4 '20: -0.43 Q1 '21: -0.45 Q4 '20 Q1 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.